← All trials
NCT05235542
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 12, 2022
- Primary completion
- Mar 31, 2023
- Completion date
- Mar 31, 2024
- First posted
- Feb 11, 2022
- Last posted
- Aug 11, 2022
- Enrollment
- 130
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Akeso Pharmaceuticals, Inc.Lead sponsor
- Jiao Tong UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.